Karan Singh, MD, ACG, offers predictions for the pharmaceutical sector for 2024 and beyond.
“We are already witnessing the result of AI and machine learning making an impact across industries and this is especially true for the pharmaceutical sector. As an example, ACG Capsule’s facility in Pithampur (India), which recently became part of the WEF Global Lighthouse Network (https://theprint.in/ani-press-releases/acg-joins-coveted-list-of-wefs-global-lighthouse-network/1891081/), is already benefitting from its adoption of industrial internet of things (IIoT), machine learning (ML), deep learning (DL), digital twins, augmented reality and generative AI. ACG has demonstrated accelerated deployment of GenAI seeking to address the changing needs for employee skill sets in manufacturing, the company developed and deployed an SOP and policy interfacing GenAI assistant in just two weeks.
“In the coming year, we’ll see the impact of these ‘fourth industrial revolution’ technologies step up pharmaceutical manufacturing even further – helping facilities to make the most of their workforce talent.
“Robotics and automation will extend the capabilities of teams, helping to deliver on the industry’s commitment to excellence and to operating facilities that are leading technological innovation through advanced manufacturing.
“The use of digital twins will become more widespread in product testing and optimisation as well as the reduction of material waste and storage costs. We’ll also see more adoption toward Gen AI and robotics in factories; humans working side by side with machines to drive new ideas and innovation – making the industry safer, more efficient and more connected.”
